{"count": 11, "results": [{"_id": "32156291", "pmid": 32156291, "pmcid": "PMC7063824", "title": "Metformin effect on gut microbiota: insights for HIV-related inflammation", "journal": "AIDS Res Ther", "authors": ["Ouyang J", "Isnard S", "Lin J", "Fombuena B", "Marette A", "Routy B", "Chen Y", "Routy JP"], "date": "2020-03-10T00:00:00Z", "doi": "10.1186/s12981-020-00267-2", "meta_date_publication": "2020 Mar 10", "meta_volume": "17", "meta_issue": "1", "meta_pages": "10", "score": 50276.2, "text_hl": "Inspired by the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@-related @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@gut dysbiosis@@@, we herein critically review the relevance of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to control @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in PLWH. ", "citations": {"NLM": "Ouyang J, Isnard S, Lin J, Fombuena B, Marette A, Routy B, Chen Y, Routy JP. Metformin effect on gut microbiota: insights for HIV-related inflammation AIDS Res Ther. 2020 Mar 10;17(1):10. PMID: 32156291", "BibTeX": "@article{32156291, title={Metformin effect on gut microbiota: insights for HIV-related inflammation}, author={Ouyang J and Isnard S and Lin J and Fombuena B and Marette A and Routy B and Chen Y and Routy JP}, journal={AIDS Res Ther}, volume={17}, number={1}, pages={10}}"}}, {"_id": "34496884", "pmid": 34496884, "pmcid": "PMC8424801", "title": "Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis", "journal": "Lipids Health Dis", "authors": ["Huang SW", "Ou YC", "Tang KS", "Yu HR", "Huang LT", "Tain YL", "Lin IC", "Sheen JM", "Hou CY", "Tsai CC", "Tiao MM"], "date": "2021-09-08T00:00:00Z", "doi": "10.1186/s12944-021-01521-w", "meta_date_publication": "2021 Sep 8", "meta_volume": "20", "meta_issue": "1", "meta_pages": "100", "score": 50275.414, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates maternal high-fat diet-induced maternal @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@dysbiosis@@@ and fetal @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver@@@ apoptosis", "citations": {"NLM": "Huang SW, Ou YC, Tang KS, Yu HR, Huang LT, Tain YL, Lin IC, Sheen JM, Hou CY, Tsai CC, Tiao MM. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis Lipids Health Dis. 2021 Sep 8;20(1):100. PMID: 34496884", "BibTeX": "@article{34496884, title={Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis}, author={Huang SW and Ou YC and Tang KS and Yu HR and Huang LT and Tain YL and Lin IC and Sheen JM and Hou CY and Tsai CC and Tiao MM}, journal={Lipids Health Dis}, volume={20}, number={1}, pages={100}}"}}, {"_id": "34264978", "pmid": 34264978, "pmcid": "PMC8282009", "title": "Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation", "journal": "PLoS One", "authors": ["Yan N", "Wang L", "Li Y", "Wang T", "Yang L", "Yan R", "Wang H", "Jia S"], "date": "2021-07-15T00:00:00Z", "doi": "10.1371/journal.pone.0254321", "meta_date_publication": "2021", "meta_volume": "16", "meta_issue": "7", "meta_pages": "e0254321", "score": 50274.07, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ intervention ameliorates @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@AS@@@ in ApoE-/- @SPECIES_10090 @@@mice@@@ through restoring gut @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@dysbiosis@@@ and anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@", "citations": {"NLM": "Yan N, Wang L, Li Y, Wang T, Yang L, Yan R, Wang H, Jia S. Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation PLoS One. 2021;16(7):e0254321. PMID: 34264978", "BibTeX": "@article{34264978, title={Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation}, author={Yan N and Wang L and Li Y and Wang T and Yang L and Yan R and Wang H and Jia S}, journal={PLoS One}, volume={16}, number={7}, pages={e0254321}}"}}, {"_id": "34579018", "pmid": 34579018, "pmcid": "PMC8467704", "title": "Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats", "journal": "Nutrients", "authors": ["Kangwan N", "Pratchayasakul W", "Kongkaew A", "Pintha K", "Chattipakorn N", "Chattipakorn SC"], "date": "2021-09-09T00:00:00Z", "doi": "10.3390/nu13093141", "meta_date_publication": "2021 Sep 9", "meta_volume": "13", "meta_issue": "9", "meta_pages": "", "score": 50268.13, "text_hl": "Although 100 and 500 mg/kg/day of @CHEMICAL_perilla_seed_oil @CHEMICAL_MESH:C058216 @@@PSO@@@ attenuated @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@gut dysbiosis@@@, particularly the percentage of Enterobacteriaceae, in HFD-fed @SPECIES_10116 @@@rats@@@ in a dose-independent manner, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ had the highest efficacy in alleviating @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@gut dysbiosis@@@.", "citations": {"NLM": "Kangwan N, Pratchayasakul W, Kongkaew A, Pintha K, Chattipakorn N, Chattipakorn SC. Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats Nutrients. 2021 Sep 9;13(9):. PMID: 34579018", "BibTeX": "@article{34579018, title={Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats}, author={Kangwan N and Pratchayasakul W and Kongkaew A and Pintha K and Chattipakorn N and Chattipakorn SC}, journal={Nutrients}, volume={13}, number={9}}"}}, {"_id": "37247620", "pmid": 37247620, "pmcid": "PMC10508460", "title": "Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders", "journal": "Chin Med J (Engl)", "authors": ["Zaongo SD", "Chen Y"], "date": "2023-05-29T00:00:00Z", "doi": "10.1097/CM9.0000000000002493", "meta_date_publication": "2023 May 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.28, "text_hl": "Overview of the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on exhaustion, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, and @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@gut dysbiosis@@@. ", "citations": {"NLM": "Zaongo SD, Chen Y. Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders Chin Med J (Engl). 2023 May 29;():. PMID: 37247620", "BibTeX": "@article{37247620, title={Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders}, author={Zaongo SD and Chen Y}, journal={Chin Med J (Engl)}}"}}, {"_id": "33678036", "pmid": 33678036, "title": "Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.", "journal": "Hum Exp Toxicol", "authors": ["Seif El-Din SH", "Salem MB", "El-Lakkany NM", "Hammam OA", "Nasr SM", "Okasha H", "Ahmed LA", "Saleh S", "Botros SS"], "date": "2021-09-01T00:00:00Z", "doi": "10.1177/0960327121999445", "meta_date_publication": "2021 Sep", "meta_volume": "40", "meta_issue": "9", "meta_pages": "1496-1509", "score": 50249.64, "text_hl": "Early intervention with probiotics and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alleviates @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@ in @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@ @SPECIES_10116 @@@rats@@@ via targeting gut @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@microbiota dysbiosis@@@ and p-@GENE_AKT1 @GENE_24185 @@@AKT@@@/@GENE_MTOR @GENE_56718 @@@mTOR@@@/@GENE_MAP1LC3A @GENE_362245 @@@LC-3II@@@ pathways.", "citations": {"NLM": "Seif El-Din SH, Salem MB, El-Lakkany NM, Hammam OA, Nasr SM, Okasha H, Ahmed LA, Saleh S, Botros SS. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways. Hum Exp Toxicol. 2021 Sep;40(9):1496-1509. PMID: 33678036", "BibTeX": "@article{33678036, title={Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.}, author={Seif El-Din SH and Salem MB and El-Lakkany NM and Hammam OA and Nasr SM and Okasha H and Ahmed LA and Saleh S and Botros SS}, journal={Hum Exp Toxicol}, volume={40}, number={9}, pages={1496-1509}}"}}, {"_id": "34749618", "pmid": 34749618, "title": "The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.", "journal": "Curr Diabetes Rev", "authors": ["Ala M"], "date": "2022-01-01T00:00:00Z", "doi": "10.2174/1573399818666211105125129", "meta_date_publication": "2022", "meta_volume": "18", "meta_issue": "8", "meta_pages": "e051121197762", "score": 50243.77, "text_hl": "Potential mechanisms by which @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may decrease @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@ risk include its effects on ameliorating @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@intestinal inflammation@@@ and @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@dysbiosis@@@, suppressing major proliferative pathways, preventing DNA replication, accelerating @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ cells apoptosis, inhibiting intra-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ angiogenesis and epithelial-mesenchymal transition (EMT), increasing @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@-infiltrating lymphocytes and @GENE_CD68 @GENE_968 @@@CD68@@@+ @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@-associated macrophages, and enhancing T cells cytotoxic activity. ", "citations": {"NLM": "Ala M. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer. Curr Diabetes Rev. 2022;18(8):e051121197762. PMID: 34749618", "BibTeX": "@article{34749618, title={The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.}, author={Ala M}, journal={Curr Diabetes Rev}, volume={18}, number={8}, pages={e051121197762}}"}}, {"_id": "33810955", "pmid": 33810955, "title": "Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Tian R", "Liu H", "Feng S", "Wang H", "Wang Y", "Wang Y", "Liang L", "Xu H", "Xing H", "Zhang S"], "date": "2021-05-06T00:00:00Z", "doi": "10.1016/j.numecd.2021.01.007", "meta_date_publication": "2021 May 6", "meta_volume": "31", "meta_issue": "5", "meta_pages": "1454-1466", "score": 50231.62, "text_hl": "Our study also addressed how @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may confound @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@gut dysbiosis@@@ and increase the potential for nitrogen metabolism. ", "citations": {"NLM": "Tian R, Liu H, Feng S, Wang H, Wang Y, Wang Y, Liang L, Xu H, Xing H, Zhang S. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis. Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1454-1466. PMID: 33810955", "BibTeX": "@article{33810955, title={Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.}, author={Tian R and Liu H and Feng S and Wang H and Wang Y and Wang Y and Liang L and Xu H and Xing H and Zhang S}, journal={Nutr Metab Cardiovasc Dis}, volume={31}, number={5}, pages={1454-1466}}"}}, {"_id": "30524735", "pmid": 30524735, "pmcid": "PMC6276176", "title": "Separating \"good\" from \"bad\" faecal dysbiosis - evidence from two cross-sectional studies", "journal": "BMC Obes", "authors": ["Farup PG", "Aasbrenn M", "Valeur J"], "date": "2018-12-03T00:00:00Z", "doi": "10.1186/s40608-018-0207-3", "meta_date_publication": "2018", "meta_volume": "5", "meta_issue": "", "meta_pages": "30", "score": 50083.27, "text_hl": "The @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@dysbiosis@@@ is, therefore, \"good\" for the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Farup PG, Aasbrenn M, Valeur J. Separating \"good\" from \"bad\" faecal dysbiosis - evidence from two cross-sectional studies BMC Obes. 2018;5():30. PMID: 30524735", "BibTeX": "@article{30524735, title={Separating \"good\" from \"bad\" faecal dysbiosis - evidence from two cross-sectional studies}, author={Farup PG and Aasbrenn M and Valeur J}, journal={BMC Obes}, volume={5}, pages={30}}"}}, {"_id": "29988585", "pmid": 29988585, "pmcid": "PMC6026676", "title": "Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling", "journal": "Front Physiol", "authors": ["Rosario D", "Benfeitas R", "Bidkhori G", "Zhang C", "Uhlen M", "Shoaie S", "Mardinoglu A"], "date": "2018-06-25T00:00:00Z", "doi": "10.3389/fphys.2018.00775", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "775", "score": 50056.01, "text_hl": "...@<m>DISEASE_Dysbiosis</m> @DISEASE_MESH:D064806 @@@Dysbiosis@@@ in the gut microbiome composition may be promoted by therapeutic drugs such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, the world's most prescribed antidiabetic drug. ", "citations": {"NLM": "Rosario D, Benfeitas R, Bidkhori G, Zhang C, Uhlen M, Shoaie S, Mardinoglu A. Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling Front Physiol. 2018;9():775. PMID: 29988585", "BibTeX": "@article{29988585, title={Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling}, author={Rosario D and Benfeitas R and Bidkhori G and Zhang C and Uhlen M and Shoaie S and Mardinoglu A}, journal={Front Physiol}, volume={9}, pages={775}}"}}]}